 Lisa Ku
Concepts (112)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Percutaneous Coronary Intervention | 1 | 2026 | 549 | 0.640 |
Why?
| | Cardiomyopathy, Dilated | 6 | 2007 | 356 | 0.390 |
Why?
| | Taiwan | 2 | 2026 | 48 | 0.300 |
Why?
| | Genetic Counseling | 2 | 2008 | 80 | 0.250 |
Why?
| | Genetics, Medical | 1 | 2006 | 23 | 0.250 |
Why?
| | Genetic Diseases, Inborn | 1 | 2006 | 45 | 0.240 |
Why?
| | Health Expenditures | 1 | 2024 | 194 | 0.180 |
Why?
| | Neoplasms, Cystic, Mucinous, and Serous | 1 | 2021 | 27 | 0.160 |
Why?
| | Ascites | 1 | 2021 | 48 | 0.160 |
Why?
| | Chronic Disease | 1 | 2026 | 1808 | 0.160 |
Why?
| | Renal Dialysis | 1 | 2024 | 466 | 0.150 |
Why?
| | Ovarian Neoplasms | 2 | 2021 | 595 | 0.150 |
Why?
| | Genetic Predisposition to Disease | 3 | 2008 | 2378 | 0.150 |
Why?
| | Precision Medicine | 1 | 2024 | 459 | 0.150 |
Why?
| | Mutation, Missense | 3 | 2005 | 335 | 0.150 |
Why?
| | Glycogen Storage Disease Type IIb | 2 | 2007 | 27 | 0.120 |
Why?
| | Genetic Testing | 4 | 2021 | 480 | 0.110 |
Why?
| | Pedigree | 5 | 2007 | 515 | 0.100 |
Why?
| | Hospitalization | 1 | 2024 | 2460 | 0.100 |
Why?
| | Retrospective Studies | 3 | 2026 | 17291 | 0.090 |
Why?
| | Aged | 4 | 2026 | 26153 | 0.080 |
Why?
| | Treatment Outcome | 1 | 2026 | 11772 | 0.080 |
Why?
| | Middle Aged | 6 | 2026 | 36215 | 0.080 |
Why?
| | Genes, Dominant | 3 | 2007 | 100 | 0.080 |
Why?
| | Female | 11 | 2026 | 78845 | 0.070 |
Why?
| | Consumer Health Information | 1 | 2008 | 49 | 0.070 |
Why?
| | Desmin | 1 | 2007 | 24 | 0.060 |
Why?
| | Male | 9 | 2026 | 72843 | 0.060 |
Why?
| | Retinitis Pigmentosa | 1 | 2006 | 20 | 0.060 |
Why?
| | Humans | 13 | 2026 | 145475 | 0.060 |
Why?
| | Myopia | 1 | 2006 | 59 | 0.060 |
Why?
| | BRCA1 Protein | 2 | 2021 | 82 | 0.060 |
Why?
| | Risk | 2 | 2008 | 919 | 0.060 |
Why?
| | Ventricular Myosins | 1 | 2005 | 39 | 0.060 |
Why?
| | Physicians, Family | 1 | 2006 | 176 | 0.060 |
Why?
| | Age of Onset | 1 | 2006 | 555 | 0.050 |
Why?
| | Sodium Channels | 1 | 2004 | 63 | 0.050 |
Why?
| | Myosin Heavy Chains | 1 | 2005 | 183 | 0.050 |
Why?
| | Cardiomyopathy, Hypertrophic | 1 | 2005 | 143 | 0.050 |
Why?
| | Arteriovenous Shunt, Surgical | 1 | 2024 | 20 | 0.050 |
Why?
| | Point Mutation | 1 | 2004 | 240 | 0.050 |
Why?
| | Amino Acid Substitution | 1 | 2004 | 302 | 0.050 |
Why?
| | Cataract | 1 | 2006 | 238 | 0.050 |
Why?
| | Biological Specimen Banks | 1 | 2024 | 109 | 0.050 |
Why?
| | Mutation | 3 | 2008 | 4075 | 0.040 |
Why?
| | Arrhythmias, Cardiac | 1 | 2004 | 355 | 0.040 |
Why?
| | Linear Models | 1 | 2024 | 845 | 0.040 |
Why?
| | Vascular Endothelial Growth Factor Receptor-2 | 1 | 2021 | 86 | 0.040 |
Why?
| | BRCA2 Protein | 1 | 2021 | 68 | 0.040 |
Why?
| | Proportional Hazards Models | 1 | 2024 | 1327 | 0.040 |
Why?
| | Referral and Consultation | 1 | 2006 | 867 | 0.040 |
Why?
| | Germ-Line Mutation | 1 | 2021 | 176 | 0.040 |
Why?
| | Gene Frequency | 1 | 2021 | 487 | 0.040 |
Why?
| | Membrane Proteins | 1 | 2005 | 1164 | 0.040 |
Why?
| | Practice Guidelines as Topic | 1 | 2006 | 1581 | 0.030 |
Why?
| | Genomics | 1 | 2024 | 825 | 0.030 |
Why?
| | DNA-Binding Proteins | 1 | 2005 | 1480 | 0.030 |
Why?
| | Pediatrics | 1 | 2006 | 1121 | 0.030 |
Why?
| | Databases, Factual | 1 | 2024 | 1490 | 0.030 |
Why?
| | Colorado | 2 | 2024 | 4554 | 0.030 |
Why?
| | Sequence Analysis, DNA | 1 | 2021 | 777 | 0.030 |
Why?
| | Kidney Failure, Chronic | 1 | 2024 | 599 | 0.030 |
Why?
| | Health Knowledge, Attitudes, Practice | 1 | 2006 | 1419 | 0.030 |
Why?
| | Adult | 5 | 2024 | 40777 | 0.030 |
Why?
| | Lysosomal-Associated Membrane Protein 2 | 2 | 2007 | 32 | 0.030 |
Why?
| | Tumor Suppressor Protein p53 | 1 | 2021 | 534 | 0.030 |
Why?
| | Breast Neoplasms | 1 | 2008 | 2382 | 0.030 |
Why?
| | Heterozygote | 2 | 2005 | 313 | 0.030 |
Why?
| | Time Factors | 1 | 2024 | 7123 | 0.020 |
Why?
| | Marketing of Health Services | 1 | 2008 | 15 | 0.020 |
Why?
| | Phenotype | 2 | 2007 | 3155 | 0.020 |
Why?
| | Women | 1 | 2008 | 47 | 0.020 |
Why?
| | Aged, 80 and over | 1 | 2021 | 8333 | 0.020 |
Why?
| | Genetic Carrier Screening | 1 | 2007 | 32 | 0.020 |
Why?
| | Frameshift Mutation | 1 | 2006 | 31 | 0.020 |
Why?
| | Pigment Epithelium of Eye | 1 | 2006 | 36 | 0.010 |
Why?
| | Electroretinography | 1 | 2006 | 50 | 0.010 |
Why?
| | Visual Fields | 1 | 2006 | 116 | 0.010 |
Why?
| | Lamin Type A | 1 | 2005 | 49 | 0.010 |
Why?
| | Microscopy, Fluorescence | 1 | 2007 | 408 | 0.010 |
Why?
| | Molecular Epidemiology | 1 | 2005 | 73 | 0.010 |
Why?
| | Fluorescein Angiography | 1 | 2006 | 190 | 0.010 |
Why?
| | Sarcomeres | 1 | 2005 | 97 | 0.010 |
Why?
| | Chromosomes, Human, Pair 3 | 1 | 2004 | 43 | 0.010 |
Why?
| | NAV1.5 Voltage-Gated Sodium Channel | 1 | 2004 | 16 | 0.010 |
Why?
| | Conserved Sequence | 1 | 2005 | 244 | 0.010 |
Why?
| | Transfection | 1 | 2007 | 926 | 0.010 |
Why?
| | Family Health | 1 | 2005 | 191 | 0.010 |
Why?
| | DNA Mutational Analysis | 1 | 2005 | 407 | 0.010 |
Why?
| | Protein Isoforms | 1 | 2005 | 397 | 0.010 |
Why?
| | HeLa Cells | 1 | 2005 | 632 | 0.010 |
Why?
| | Chromatography, Liquid | 1 | 2005 | 450 | 0.010 |
Why?
| | Protein Structure, Tertiary | 1 | 2005 | 855 | 0.010 |
Why?
| | Exons | 1 | 2004 | 363 | 0.010 |
Why?
| | Haplotypes | 1 | 2004 | 499 | 0.010 |
Why?
| | Myocytes, Cardiac | 1 | 2007 | 546 | 0.010 |
Why?
| | Health Promotion | 1 | 2008 | 775 | 0.010 |
Why?
| | Gene Expression | 1 | 2007 | 1476 | 0.010 |
Why?
| | Ventricular Dysfunction, Left | 1 | 2005 | 394 | 0.010 |
Why?
| | Myocardium | 1 | 2005 | 934 | 0.010 |
Why?
| | Prevalence | 1 | 2007 | 2865 | 0.010 |
Why?
| | Cells, Cultured | 1 | 2007 | 4148 | 0.010 |
Why?
| | Rats | 1 | 2007 | 5584 | 0.010 |
Why?
| | Registries | 1 | 2007 | 2406 | 0.010 |
Why?
| | Case-Control Studies | 1 | 2005 | 3623 | 0.010 |
Why?
| | Cohort Studies | 1 | 2007 | 6013 | 0.010 |
Why?
| | Muscle, Skeletal | 1 | 2005 | 1789 | 0.010 |
Why?
| | Infant | 1 | 2007 | 10077 | 0.010 |
Why?
| | Heart Failure | 1 | 2005 | 2326 | 0.010 |
Why?
| | United States | 1 | 2007 | 16098 | 0.000 |
Why?
| | Adolescent | 1 | 2007 | 22530 | 0.000 |
Why?
| | Animals | 1 | 2007 | 38030 | 0.000 |
Why?
|
|
Ku's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|